The Supreme Court has issued a ruling allowing continued access to the abortion pill mifepristone via mail and telehealth services. This decision means the widely used medication will remain available through these distribution methods for the time being.
This order from the nation's highest court preserves the current availability of mifepristone as a lawsuit challenging its access proceeds through lower courts. The justices' action ensures that patients can still receive the medication through the mail.
The ruling maintains the status quo regarding the distribution of the abortion pill. This is a developing story and will be updated as details emerge.
